Stratifying Critically Ill Patients for Novel Ferroptosis or Pyroptosis Intervention Strategies

Recruiting N/A Interventional Study
Sepsis Trauma Related Injuries Subarachnoid Haemorrhage (SAH)
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
600 (estimated)
Sponsor
University Hospital, Antwerp · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
In order to better determine which therapy is best for patiënts which present with organ falure during the course of their stay in the intesive care unit (ICU) , one has to determine which underlying mechanism is causing this organ falure. We will determine levels of so called "biomarkers" for ferroptosis (a mechan ism of iron-related cell death) in the peripheral blood and biological fluids of cr…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Admitted to the ICU of UZA * Critically ill and predicted to be hospitalised in the ICU for \> 48 hours (i.e. mostly patients admitted for sepsis, trauma, haemorrhagic shock, neurological catastrophe … which means at risk to develop mono-or multiple organ failure) * With arter…
Contacts

Tom Stroobants, MD

+32 3 821 / 24 52

tom.stroobants@uza.be

CONTACT